In This Article:
As global markets respond to a mix of easing inflation and varied economic signals, the Swedish stock exchange presents a unique landscape for investors interested in growth companies with high insider ownership. This focus can offer insights into firms where leadership has significant skin in the game, potentially aligning management's interests with those of shareholders especially in an environment marked by shifting economic indicators.
Top 10 Growth Companies With High Insider Ownership In Sweden
Name | Insider Ownership | Earnings Growth |
CTT Systems (OM:CTT) | 16.9% | 21.6% |
Biovica International (OM:BIOVIC B) | 18.5% | 73.8% |
edyoutec (NGM:EDYOU) | 14.6% | 63.1% |
Sileon (OM:SILEON) | 20.3% | 109.3% |
KebNi (OM:KEBNI B) | 37.8% | 90.4% |
Yubico (OM:YUBICO) | 37.5% | 43.8% |
InCoax Networks (OM:INCOAX) | 18.1% | 104.9% |
BioArctic (OM:BIOA B) | 34% | 50.9% |
Calliditas Therapeutics (OM:CALTX) | 11.6% | 52.9% |
SaveLend Group (OM:YIELD) | 23.3% | 103.4% |
Here's a peek at a few of the choices from the screener.
BioArctic
Simply Wall St Growth Rating: ★★★★★★
Overview: BioArctic AB, based in Sweden, specializes in developing biological drugs for central nervous system disorders and has a market capitalization of SEK 20.85 billion.
Operations: The company generates SEK 252.21 million from its biotechnology segment, focusing on biological drugs for central nervous system disorders.
Insider Ownership: 34%
Earnings Growth Forecast: 50.9% p.a.
BioArctic, a Swedish biopharma firm with significant insider ownership, has recently seen approval in South Korea for its Alzheimer's treatment, Leqembi®, enhancing its product portfolio. Despite a challenging Q1 in 2024 with a shift from profit to loss, the company is poised for recovery with anticipated high revenue growth (40.8% per year) and return to profitability within three years. Strategic alliances like the ongoing collaboration with Eisai Co., Ltd., underscore its commitment to innovation in Alzheimer's therapy.
-
Click here and access our complete growth analysis report to understand the dynamics of BioArctic.
-
Our valuation report here indicates BioArctic may be undervalued.
Pandox
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Pandox AB (publ) is a global hotel property company that owns, develops, and leases hotel properties with a market capitalization of approximately SEK 38.33 billion.
Operations: The company generates revenue primarily through two segments: own operation, which brought in SEK 3.27 billion, and rental agreements, contributing SEK 3.82 billion.